Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
本文描述了
化学因子受体拮抗剂,特别是式(I)化合物,其作为
趋化因子CCR2受体的拮抗剂,包括制药组合物及其用于治疗或预防与单核细胞聚集、淋巴细胞聚集或白细胞聚集相关的疾病。